Developing neurons depend on neurotrophins supplied by the tissues they innervate. Before and after this period of target-dependent survival, brainderived neurotrophic factor also has autocrine actions on some neurons.
In the developing vertebrate nervous system, many neurons die shortly after their axons reach their targets. This loss is thought to match the number of neurons to the size and requirements of their target fields, because altering target-field size prior to innervation affects the number of neurons that survive. Work on nerve growth factor (NGF), the founder member of the neurotrophin family of secreted proteins, has led to the widely accepted view that target fields regulate their innervation density by producing limited quantities of factors that the innervating neurons require for their survival [1] .
NGF is synthesized in the targets of NGF-dependent sensory and sympathetic neurons in proportion to their final innervation density, and experimental manipulation of the level of NGF during development affects the number of neurons that survive. Exogenous NGF rescues neurons that would otherwise die, whereas anti-NGF antibodies, or targeted null mutations in the genes encoding NGF itself or the NGF receptor tyrosine kinase eliminate NGF-dependent neurons. In addition to promoting neuronal survival during development, targetderived NGF also has a profound effect on regional differences in axonal branching throughout life [2, 3] . More recently identified neurotrophins -brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT3) and neurotrophin-4/5 (NT4/5) -also promote the survival of distinctive sets of developing neurons [1] .
The survival of sensory neurons depends on targetderived neurotrophins for only a limited period during development [1] . When cultured at low density during the stage of development at which their axons are growing to their targets, sensory neurons survive without added neurotrophins in the culture medium. At the stage when their axons would have reached their targets in vivo, however, the cultured sensory neurons die unless they are exposed to the appropriate neurotrophin. Throughout the ensuing phase of naturally occurring neuronal death, and for some time beyond, different classes of sensory neurons depend for their survival on the supply of one or more specific neurotrophins [1] . By adulthood, dorsal root ganglion (DRG) sensory neurons no longer require NGF for survival in vivo [4] and can survive in vitro without added NGF or BDNF [5] .
Although various neurotrophins are expressed in the peripheral and central targets of sensory neurons during development [1] , the discovery that mRNAs for BDNF and NT3 are present in subsets of DRG neurons [6, 7] , which themselves respond to these factors, has raised the possibility that BDNF or NT3 could act by an autocrine route. Studies using antisense BDNF oligonucleotides to inhibit translation of BDNF mRNA in cultures of DRG neurons have indeed provided evidence for the operation of BDNF autocrine loops during periods of target-independent survival.
A BDNF autocrine loop in early DRG neurons
The first direct experimental evidence that neurotrophins can act by an autocrine route came from studies of DRG neurons cultured in vitro after isolation from chicken embryos at the stage when their axons are growing to their targets [8] . These early sensory neurons undergo a clearly recognizable morphological transition during the first 24 hours in culture, before they become dependent on added neurotrophins for survival. Initially, the neurons have small, spindle-shaped, phase-dark cell bodies and short neurites. Subsequently, they develop spherical, phase-bright cell bodies and extend long neurites ( Fig. 1 ). Although the rate at which this maturational change takes place is accelerated by exposure to either BDNF or NT3, the neurons need not obtain these factors from other cells to mature -they still mature when cultured as single cells in separate culture wells containing chemically defined media without added neurotrophins.
Because early DRG cells express BDNF mRNA, as revealed by amplification using the reverse transcriptioncoupled polymerase chain reaction (RT-PCR), antisense BDNF oligonucleotides were used to investigate whether BDNF might act by an autocrine route to promote maturation [8] . Each of three different antisense BDNF oligonucleotides, but none of the corresponding sense control oligonucleotides, reduced by 40-50 % the number of neurons that underwent the maturational change. The inhibition of neuronal maturation by antisense BDNF oligonucleotides was not due to a non-specific reduction of protein synthesis, because the effect of the oligonucleotides could be specifically reversed by adding BDNF to the culture medium. The antisense BDNF affected only the maturation of early DRG neurons and not their survival, indicating that the BDNF autocrine loop is not required for survival at this stage.
A BDNF autocrine loop in adult DRG neurons Acheson and colleagues [9] have recently used a similar experimental approach to demonstrate the operation of a BDNF autocrine loop in adult DRG neurons. In contrast to the situation in early sensory neurons, the BDNF [8] .
autocrine loop at this stage appears to be required for the survival of a subset of sensory neurons. Three antisense BDNF oligonucleotides, but not the sense control oligonucleotides, reduced the number of surviving neurons by 35 % in single-neuron cultures. To exclude the possibility that this reduced neuronal survival was due to non-specific toxicity, these workers also showed that the effects of antisense BDNF oligonucleotides could be reversed by adding BDNF to the culture medium. However, in contrast to the very low concentrations of BDNF that are sufficient completely to reverse the effects of antisense BDNF oligonucleotides on early DRG neurons (20 pg ml-1) [8] , levels of BDNF almost four orders of magnitude higher were required to achieve complete reversal in adult DRG neurons (100-200 ng ml-). Whether adult DRG neurons are far less responsive to BDNF than developing neurons, or whether BDNF is acting as a neuroprotectant at these very high concentrations, is unclear from these experiments.
To exclude further the possibility of oligonucleotide toxicity, DRG cultures were set up from mice that are homozygous for a null mutation in the BDNF gene. In these cultures, antisense BDNF oligonucleotides did not reduce the survival of the DRG neurons from one BDNF-deficient animal, but they caused a 20-25 % reduction in the survival of DRG neurons from another. Thus, the reduction in neuronal survival by antisense BDNF oligonucleotides, which was associated with an 80 % reduction in BDNF protein levels in these cultures, cannot be attributed entirely to toxicity; rather it provides evidence for the operation of a BDNF autocrine loop in a subset of adult DRG neurons. Figure 2 illustrates the different stages in the life history of sensory neurons during which BDNF autocrine loops are likely to operate.
Do autocrine loops operate during the phase of neuronal cell death?
The demonstration that BDNF mRNA is expressed in a subset of embryonic DRG neurons during the period when naturally occurring neuronal death is taking place [7] has raised the possibility that BDNF might act by an autocrine route in some neurons during this period of development. But measurement of BDNF mRNA in different populations of cranial sensory neurons that respond to either NGF or BDNF has shown that, during the phase of naturally occurring neuronal death, BDNF mRNA is expressed predominantly in neurons that respond to NGF, not BDNF (M. Robinson and A.M.D., unpublished observations). Furthermore, sensory neurons die very rapidly at this stage when cultured without neurotrophins [1] . Thus, during the period of naturally occurring neuronal death, BDNF is unlikely to act by an autocrine route in most sensory neurons. This makes good sense, because an autocrine loop at this time would interfere with the selection of neurons by target-derived neurotrophins. It is possible, however, that the BDNF made by NGF-dependent sensory neurons during this stage acts on other cells, such as the neurons in the central nervous system with which they synapse.
Although studies in vitro using antisense BDNF oligonucleotides have provided compelling evidence for the operation of BDNF autocrine loops in embryonic and adult DRG neurons, the magnitude of the antisense effects does not necessarily indicate how many neurons DISPATCH 725 compare the results of these studies, because probes that recognize different trkB variants were used, and because in the former study trkB expression in the whole ganglion was analyzed, whereas in the latter study trkB expression was analyzed specifically in the subsets of neurons that innervate different peripheral targets.
There remain a number of unresolved issues concerning the postulated BDNF autocrine loop. In addition to ascertaining how the loop is switched off and on, and whether the same neurons that have an autocrine loop early in development re-acquire this loop later on, it will be important to determine whether BDNF acts intracellularly, or whether it has to be secreted in order to act on BDNF receptors. The use of specific BDNF-neutralizing antisera added to the culture medium may help to clarify this issue.
The expression of NT3 mRNA in a subset of DRG neurons [6, 7] raises the issue of whether NT3 autocrine loops also operate in some sensory neurons. Consistent with this possibility is the demonstration that the maturation of early DRG neurons is accelerated by NT3 and inhibited by antisense oligonucleotides that reduce expression of p75, a common low-affinity receptor for NT3 and other neurotrophins [8] . Because each of the three antisense p75 oligonucleotides used in this study was more effective in preventing maturation than were antisense BDNF oligonucleotides [8] , it is possible that another p75 ligand, such as NT3, plays a role in promoting maturation.
Fig. 2.
Stages in the life history of DRG sensory neurons when BDNF autocrine loops are likely to operate. Before sensory neurons have started to innervate their targets and become dependent on target-derived neurotrophins for survival, a BDNF autocrine loop accelerates an early maturational change in a proportion of these neurons, but BDNF is not required for their survival at this stage. During the phase of naturally occurring neuronal death, when the targets selectively support the survival of the appropriate number of innervating neurons, the targets are likely to be the most important source of BDNF for sensory neurons. In the adult, when the neurons once again become independent of target-derived neurotrophins for survival, a BDNF autocrine loop promotes the survival of a subset of DRG neurons. are involved. Because antisense BDNF oligonucleotides may not inhibit the BDNF autocrine loop completely, it is possible that the loop operates in more neurons than are affected by the oligonucleotides. This implies that the autocrine loop must be turned off in many neurons prior to the phase of naturally occurring neuronal death, and turned on again in many neurons at a later stage. This might be achieved by regulating the expression of either BDNF, its receptor TrkB, or both, in specific subsets of DRG neurons during development. Detailed studies of the numbers of DRG neurons expressing BDNF and TrkB at different ages may help to resolve this question. Analysis of trkB mRNA expression in rat DRG neurons by in situ hybridization suggests that fewer neurons express trkB mRNA in embryos and postnatal animals [10] than in the adult [11] . However, it is difficult to Using combined isotopic and non-isotopic in situ hybridization, NGF mRNA and BDNF mRNA have been colocalized with transcripts encoding their respective receptor tyrosine kinases (TrkA and TrkB) in the same neurons in several forebrain regions [12, 13] . Among the neurons that co-express BDNF and trkB mRNAs are a major subset of cortical neurons [12, 13] . This finding, together with the demonstration that anti-BDNF antiserum reduces neuronal survival in cortical neuron cultures [14] , is consistent with the operation of a BDNF autocrine loop in certain cortical neurons, but further work will be required for it to be possible to exclude a paracrine mode of action for BDNF In addition to the co-expression of NGF and BDNF with their cognate receptors in certain subsets of neurons in the hippocampus, basal ganglia, cortex and hypothalamus, several other populations of neurons in the central nervous system express neurotrophins and respond to the same neurotrophins in culture. For example, dopaminergic neurons of the substantia nigra express BDNF mRNA and respond to BDNF with increased survival [15] , raising the possibility that BDNF may act by an autocrine route in some of these neurons. Much work is still needed to clarify how widely autocrine signalling operates in the developing and mature nervous system and to ascertain the significance of such signalling for sustaining neuronal survival and regulating other aspects of neuronal development and function.
